From protein design to synthetic patient data, we break down the categories of tech vendors bringing generative AI into the research and clinical settings.
Generative AI is permeating the healthcare landscape.
On the drug R&D front, pharma players are using the tech to design new drugs in a fraction of the time. For instance, Insilico Medicine has brought an AI-generated drug for idiopathic pulmonary fibrosis to Phase II human clinical trials — in about half the time it would take without AI. Startups here saw a flurry of exit activity in 2023 as incumbents race to get involved.
Meanwhile, in the hospital setting, genAI is helping summarize complex doctor-patient interactions, make EHR entries more precise, and enhance diagnostic imaging. Cloud giants like Microsoft and Amazon have announced clinical documentation services that allow providers to automatically create medical notes, while EHR leader Epic has partnered with Microsoft to integrate genAI tools into its EHR system.
In the market map below, we identify 53 tech vendors using generative AI to improve healthcare across 7 categories.
Please click to enlarge.
Want to see more research? Join a demo of the CB Insights platform.
If you’re already a customer, log in here.
